Read more
7:05 PM ยท 14 August 2024

NATGAS gains 5% ๐Ÿ“ˆ

Natural gas (NATGAS)-based contracts are gaining more than 5% during Wednesday's session as the disparity between supply and demand for the commodity continues. Despite large gas inventories in the U.S., data for the past few days indicate that the rate of shrinkage is increasing relatively quickly. The supply-demand balance came out below the range of the 5-year average this week, and the demand for gas itself in the context of electricity generation is growing. 

Gas production fell sharply this week, although demand for the commodity remains elevated. Source: XTB

The slowdown in production has led, for the first time since January/February of this year, to rally overall inventories against the upper limit of the 5-year historical average. An extension of this trend could lead to concerns that such a sharp reduction in production could bring stocks back to the historical average, disrupting the pro-downturn paradigm that has kept NATGAS under pressure since the beginning of the year. Source: XTB

NATGAS is currently testing a zone of resistance set by the 50- and 100-day exponential moving averages. It is the reaction to these levels that may determine whether we are in for a reversal of the downtrend, or whether the supply side, however, will decide to push NATGAS back below the 2.10 zone. Source: xStation 

23 April 2026, 10:00 PM

Daily summary: Risk-off takes over ๐Ÿ“‰ US stocks plunge, while dollar and oil rebound sharply ๐Ÿ’ธ

23 April 2026, 5:45 PM

Wheat tries to continue the uptrend despite improving US weather๐Ÿ”ŽWhat's next?

23 April 2026, 9:53 AM

Morning Wrap: Ceasefire Fuels Wall Street Gains, but Political Uncertainty Remains

22 April 2026, 10:19 PM

Daily Summary: Unilateral Ceasefire Sufficient for Wall Street

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.